申请人:Pharmacia & Upjohn, S.p.A.
公开号:US06750215B2
公开(公告)日:2004-06-15
The present invention relates to a class of compounds represented by the formula (I)
or a pharmaceutical acceptable salt, prodrug or ester thereof, pharmaceutical compositions comprising compounds of the formula (I), and methods of selectively inhibiting or antagonizing &agr;v&bgr;3 integrin.
本发明涉及一类由公式(I)表示的化合物或其药物可接受的盐、前药或酯,包括公式(I)化合物的药物组合物,并且涉及选择性抑制或拮抗αvβ3整合素的方法。